Summit Therapeutics Inc.

NASDAQ: SMMT · Real-Time Price · USD
26.67
0.22 (0.83%)
At close: Aug 15, 2025, 3:59 PM
26.50
-0.64%
After-hours: Aug 15, 2025, 07:37 PM EDT

Summit Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
104.86M 71.42M 348.61M 71.79M
Short-Term Investments
307.49M 114.82M n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
2.55M 5.28M 577K 170K
Receivables
557K 848K 349K 1.46M
Inventory
n/a n/a 301.5M 7.16M
Other Current Assets
10.84M 181K 300.49M 1.2M
Total Current Assets
423.75M 189.71M 656.71M 97.31M
Property-Plant & Equipment
7.4M 6.06M 5.08M 3.48M
Goodwill & Intangibles
1.86M 1.89M 1.8M 12.41M
Total Long-Term Assets
11.81M 13.24M 7.46M 16.06M
Total Assets
435.56M 202.95M 664.17M 113.37M
Account Payables
4.64M 2.67M 355K 4.37M
Deferred Revenue
n/a n/a n/a 7.94M
Short-Term Debt
n/a n/a 19.77M 284.24K
Other Current Liabilities
33.33M 9.5M 6.3M 5.31M
Total Current Liabilities
41.73M 20.41M 38.78M 25.62M
Long-Term Debt
n/a 100M 494.54M n/a
Other Long-Term Liabilities
1.63M 1.56M 1.43M 3.22M
Total Long-Term Liabilities
5.08M 104.85M 498.73M 4.47M
Total Liabilities
46.81M 125.26M 537.51M 30.09M
Total Debt
7.22M 106.1M 518.76M 2.78M
Common Stock
7.38M 7.02M 2.11M 980K
Retained Earnings
-1.21B -993.26M -378.33M -299.55M
Comprehensive Income
-2.29M -2.45M -1.89M -2.2M
Shareholders Equity
388.75M 77.69M 126.65M 83.28M
Total Investments
307.49M 114.82M n/a n/a